Agnostic Cys34-albumin adductomics and DNA methylation: Implication of N-acetylcysteine in lung carcinogenesis years before diagnosis

Int J Cancer. 2020 Jun 15;146(12):3294-3303. doi: 10.1002/ijc.32680. Epub 2019 Oct 31.

Abstract

Although smoking and oxidative stress are known contributors to lung carcinogenesis, their mechanisms of action remain poorly understood. To shed light into these mechanisms, we applied a novel approach using Cys34-adductomics in a lung cancer nested case-control study (n = 212). Adductomics profiles were integrated with DNA-methylation data at established smoking-related CpG sites measured in the same individuals. Our analysis identified 42 Cys34-albumin adducts, of which 2 were significantly differentially abundant in cases and controls: adduct of N-acetylcysteine (NAC, p = 4.15 × 10-3 ) and of cysteinyl-glycine (p = 7.89 × 10-3 ). Blood levels of the former were found associated to the methylation levels at 11 smoking-related CpG sites. We detect, for the first time in prospective blood samples, and irrespective of time to diagnosis, decreased levels of NAC adduct in lung cancer cases. Altogether, our results highlight the potential role of these adducts in the oxidative stress response contributing to lung carcinogenesis years before diagnosis.

Keywords: DNA-methylation; adductomics; biomarkers; lung cancer; oxidative stress; smoking.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / metabolism*
  • Biomarkers, Tumor / blood
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Carcinogenesis / genetics*
  • Case-Control Studies
  • CpG Islands / genetics
  • DNA Adducts / blood*
  • DNA Adducts / genetics
  • DNA Adducts / metabolism
  • DNA Methylation
  • Epigenomics / methods
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / blood
  • Lung Neoplasms / epidemiology*
  • Lung Neoplasms / genetics
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Prospective Studies
  • Risk Assessment / methods
  • Smoking / adverse effects*
  • Smoking / blood
  • Smoking / genetics

Substances

  • Biomarkers, Tumor
  • DNA Adducts
  • Acetylcysteine